Email this Article

Past Issues | Current Issue

Complete this form to e-mail a link to this article to a friend or colleague.

Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome

Hande Guclu and Vuslat Pelitli Gurlu.Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.Int J Ophthalmol, 2019,12(2):258-267

E-mail to: (to whom you're sending this)

Your e-mail address:

Your name:

Your comments to add to the e-mail:

Verification code: